Friday, July 17 2026
9:40–10:25am
Industry Theater
Obesity as a metabolic disease: pathophysiology, complications, and management
Industry Theater 1, Emerald I-III, Level 1
Description
This program aims to address obesity as a contributor to metabolic dysfunction. The session will explore the interplay of obesity and impact on aspects of metabolic
dysfunction. Strategies for managing obesity in clinical practice will be discussed, with the goal of improving the care of patients living with obesity.
Faculty
Sponsored by
- Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Pharmaceuticals, Inc.